Results 131 to 140 of about 2,748,395 (254)

Incretin polyagonists as an alternative to bariatric surgery to manage obesity. [PDF]

World J Gastrointest Pathophysiol
Manoj RJ, Fernandez CJ, Nair S, Pappachan JM.   +3 more
europepmc   +1 more source

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials. [PDF]

Endocrinol Diabetes Metab
Abulehia A, Ayesh H, Ayesh O, Jaber D, Asad T, Itbaisha A, Abugharbieh H, Gharbia R, Abu-Hilal LH, Leon BGC.   +9 more
europepmc   +1 more source

Quantitation of apolipoprotein e-isoforms in diabetes mellitus [PDF]

, 1983
Jüngst, Dieter, Schwandt, P., Weisweiler, P.   +2 more
core   +1 more source

Glucagon-like peptide-1 receptor (GLP1R; GLP-1R); glucagon receptor (GCGR) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research. [PDF]

Front Med (Lausanne)
Lu X, Yang L.
europepmc   +1 more source

Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.

Brain Research, 2018
Jingjing Tai, Weizhen Liu, Yanwei Li, Lin Li, C. Hölscher   +4 more
semanticscholar   +1 more source

Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control. [PDF]

Rambam Maimonides Med J
Bonga KN, Padhan M.
europepmc   +1 more source

Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders. [PDF]

Diabetes Metab Syndr Obes
Qiao Y, Zhou F, Mao T, Gao L.
europepmc   +1 more source

Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.

Molecular and Cellular Endocrinology, 2009
M. Kedees, M. Grigoryan, Y. Guz, G. Teitelman   +3 more
semanticscholar   +1 more source

Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. [PDF]

Curr Obes Rep
Tzeravini E, Simati S, Anastasiou IA, Dalamaga M, Kokkinos A.   +4 more
europepmc   +1 more source